Renaissance Technologies (RenTech)'s NAUT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 690,514 shares of Nautilus Biotechnology, Inc. (NAUT) worth $1.29 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NAUT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 424,814 shares. Largest reduction occurred in Q4 2025, reducing 747,762 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Nautilus Biotechnology (NAUT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nautilus Biotechnology (NAUT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +424,814 | Add 159.88% | 690,514 | $1.87 |
| Q1 2026 | +5,800 | Add 2.23% | 265,700 | $3.88 |
| Q4 2025 | -747,762 | Reduce 74.21% | 259,900 | $1.95 |
| Q3 2025 | +387,756 | Add 62.55% | 1.01 M | $0.84 |
| Q2 2025 | +319,450 | Add 106.32% | 619,906 | $0.72 |
| Q1 2025 | +50,235 | Add 20.08% | 300,456 | $0.86 |
| Q4 2024 | +95,521 | Add 61.75% | 250,221 | $1.68 |
| Q3 2024 | +14,600 | Add 10.42% | 154,700 | $2.85 |
| Q2 2024 | +14,100 | Add 11.19% | 140,100 | $2.34 |
| Q1 2024 | +9,300 | Add 7.97% | 126,000 | $2.94 |
| Q4 2023 | -100 | Reduce 0.09% | 116,700 | $2.99 |
| Q3 2023 | +400 | Add 0.34% | 116,800 | $3.16 |
| Q2 2023 | +6,200 | Add 5.63% | 116,400 | $0.00 |
| Q1 2023 | +10,700 | Add 10.75% | 110,200 | $0.00 |
| Q4 2022 | +10,400 | Add 11.67% | 99,500 | $0.00 |
| Q3 2022 | +25,500 | Add 40.09% | 89,100 | $2.12 |
| Q2 2022 | +52,600 | Add 478.18% | 63,600 | $2.69 |
| Q1 2022 | +11,000 | New Buy | 11,000 | $4.36 |
Renaissance Technologies (RenTech)'s Nautilus Biotechnology Investment FAQs
Renaissance Technologies (RenTech) first purchased Nautilus Biotechnology, Inc. (NAUT) in Q1 2022, acquiring 11,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Nautilus Biotechnology, Inc. (NAUT) for 18 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Nautilus Biotechnology, Inc. (NAUT) was in Q2 2026, adding 690,514 shares worth $1.29 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 690,514 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $1.29 M.
As of the Q2 2026 filing, Nautilus Biotechnology, Inc. (NAUT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Nautilus Biotechnology, Inc. (NAUT) was 1,007,662 shares, as reported at the end of Q3 2025.